Saku Biosciences

Saku Biosciences is an early stage life sciences company that aims to reduce the costs to make biotechnology products.

Health and bio

Saku Biosciences has no funding amount on record yet; its latest known round is Seed (May 2026). Recent Funding first saw it on October 2, 2026.

Founders and team

• DD
  Dino Di Carlo Founder

  source: crunchbase.com

Raise history

1. May 18, 2026
   Seed · amount undisclosed
   Source: crunchbase.com

Related bio health companies

• SSharp$328K · Oct 1, 2026
• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• AAptadir Therapeutics$45M · Sep 29, 2026
• GGoerSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/saku-biosciences.